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Abstract
Neurogenic orthostatic hypotension (NOH) is characterized by a drop in systolic blood pressure
≥20mmHg or diastolic blood pressure ≥10mmHg within three minutes of upright posture. A large
drop in blood pressure can trigger cerebral hypoperfusion, which has been linked to deficits in
cognitive function. The current thesis aimed to measure cerebral hemodynamics and cognitive
function in 20 NOH patients and 20 controls in the supine and head-up tilt (HUT) positions.
Information processing speed (IPS) was assessed using the Symbol-Digit Modalities Test and
attention was measured using the Stroop Test. NOH patients had significantly slower IPS in both
the supine(p<0.001) and HUT(p<0.001) positions and had worse attention during HUT(p=0.029)
compared to controls. During HUT, NOH patients had significantly reduced cerebral blood flow
velocity(p=0.003) and cerebral oxygen saturation(p=0.025) from baseline, whereas controls
revealed no significant changes. Decreased cerebral hemodynamics in NOH patients could be
linked to their impairment in IPS and attention.

Keywords: neurogenic orthostatic hypotension, cognitive function, information processing
speed, attention, regional cerebral oxygen saturation, cerebral blood flow velocity
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Summary for Lay Audience
Neurogenic orthostatic hypotension (NOH) is characterized by a drop in in systolic blood pressure
≥ 20mmHg or diastolic blood pressure ≥ 10mmHg within three minutes of upright posture. A
severe drop in blood pressure can cause symptoms such as lightheadedness, dizziness, weakness,
and fatigue. This thesis objected to determine if patients with NOH experienced alterations in
cognitive function with a positional change from lying to standing. Cognitive function was
assessed using the Symbol-Digit Modalities Test to measure information processing speed and the
Stroop Test to measure attention. Recent research proposed that reductions in cerebral blood
supply can accelerate the natural process of cognitive decline. Therefore, this thesis also aimed to
measure cerebral blood flow using transcranial doppler and near infrared spectroscopy to
determine if there were any differences between NOH patients and healthy control subjects. It was
found that NOH patients had significantly slower information processing speed in both the lying
and standing positions compared to controls, as well NOH patients had significantly reduced
attention in the standing position compared to controls. Patients with NOH experienced a
significant reduction in cerebral blood flow in the standing position compared to the lying position.
Repeated exposure to reduced cerebral blood flow as a result of autonomic dysfunction is likely a
contributing factor to our finding of impaired information processing speed and attention in NOH
patients. This thesis sheds new light on cognitive function and cerebral blood flow in NOH
patients.
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Chapter 1

1

Introduction

It is common knowledge that cognitive decline is a natural process of aging 1. Aging causes a
decrease in many cognitive domains including memory, spatial visualization, information
processing speed (IPS), attention, executive functioning, and conceptual reasoning1,2. Reduced IPS
can be especially problematic since it is a predictor of the ability to perform simple daily activities
and an indicator of independence

3,4

. Cognitive decline can occur at an accelerated rate in

neurodegenerative conditions like Alzheimer's disease (AD), Lewy-body dementia (LBD),
Parkinson's disease (PD), and multiple sclerosis (MS)

5,6

. There is limited literature on a

neurological condition referred to as neurogenic orthostatic hypotension (NOH) and its
relationship to cognitive decline. NOH is a cardinal feature of many neurodegenerative diseases
such as Multiple System Atrophy (MSA), PD, LBD, and pure autonomic failure (PAF), therefore
it could also be linked to accelerated cognitive decline.

NOH is characterized by a drop in systolic blood pressure (SBP) ≥ 20mmHg or diastolic blood
pressure (DBP) ≥ 10mmHg in the absence of a compensatory increase in heart rate (HR) within
three minutes of upright posture or head-up tilt (HUT). Autonomic nervous system damage can
cause inadequate release of norepinephrine, from the sympathetic nerves therefore insufficient
vasoconstriction occurs and results in a postural blood pressure (BP) drop. The severe drop in BP
causes symptoms such as lightheadedness, dizziness, weakness, and fatigue. These symptoms
make simple daily activities difficult to perform and can increase the risk of falls 7.

Prior research has stated that this large drop in BP can provoke a reduction in cerebral blood flow
8,9

. This is problematic because cerebral hypoperfusion has been linked to cognitive decline

7,10

.

There is a variety of literature related to this topic but there is very little research specifically

1

related to NOH patients and cognitive decline. Determining if alterations in cerebral blood supply
affect cognitive functioning in NOH patients will be an important addition to the current literature.
Therefore, this thesis will provide general information about the autonomic nervous system and
conditions and diseases related to autonomic dysfunction with an emphasis on NOH.
Epidemiology, diagnostic testing, and treatment of NOH will be addressed in great detail. This
thesis will also discuss how alterations in cerebral hemodynamics affect cognitive functioning,
specifically IPS and attention.

The first research study presented in this thesis aimed to investigate the potential changes in
cognitive function experienced by individuals with NOH in both the supine and HUT positions.
The study also aimed to describe the relationship between cognitive function and the change in
SBP in NOH patients. The second study presented in this thesis assessed cerebral hemodynamics
parameters including cerebral blood flow velocity (CBFv) and regional cerebral oxygen saturation
(rSO2) in NOH patients in the supine and HUT positions. This study also aimed to determine the
effects of cerebral hypoperfusion on IPS and attention.

Accordingly, the following hypotheses were made:
1. NOH patients will experience a decline in IPS and attention in the HUT position compared
to the supine position due to the associated reduction in postural BP. Controls will
experience an increase in IPS and attention in the HUT position compared to supine.
2. The magnitude of the postural SBP drop will correspond with a worsening in IPS and
attention. Therefore, the larger the drop in SBP, the worse the NOH patients will perform
on the cognitive tests.
3. NOH patients will have a reduction in CBFv and rSO2 in the HUT position compared to
the supine position, whereas controls will experience no changes in CBFv and rSO2 with
the change in position.
4. The reduced measures of CBFv and rSO2 may be related to a decline in IPS and attention.
2

Chapter 2

2

Literature Review

2.1

Autonomic Nervous System

The autonomic nervous system (ANS) unconsciously provides neural control to regulate bodily
functions such as heart rate, blood pressure, sweating, respiration, gastrointestinal motility, urinary
and bowel excretion, and reproduction. The ANS maintains homeostasis through the coordinated
control of all bodily functions 11. This system is composed of three main divisions; the sympathetic
nervous system (SNS), the parasympathetic nervous system (PNS), and the enteric nervous system.
This thesis will only focus on the SNS and PNS, which are displayed in Figure 1. The SNS and
PNS have antagonistic effects; the SNS works to increase bodily functions such as HR, breathing,
sweating, and constricts blood vessels, whereas the PNS is used to slow these high energy
functions during times of rest and digestion. Therefore, these systems work together to ensure the
balance of homeostasis.

The SNS originates in the spinal cord, specifically in the lateral grey column of T1 to L1-2 11. A
preganglionic efferent neuron exits the spinal column, synapses at a ganglion, and then continues
as a postganglionic neuron. Postganglionic neurons innervate target organs such as the eyes, heart,
lungs, stomach, intestines, bladder, sweat glands, reproductive organs, and kidneys. In the SNS
the preganglionic neurons are relatively short and are cholinergic releasing acetylcholine whereas
the postganglionic fibers are fairly long and are noradrenergic releasing norepinephrine. The
primary neurotransmitter of the SNS is norepinephrine and when released it stimulates the body
during times of increased activity 12,13.

3

The PNS originates in two primary areas. Firstly, the cranial nerves III, VII, and IX which arise in
the cranium and then synapse with a ganglia before going to their target tissues, as well as the
vagus nerve (cranial nerve X) which originates in the medulla oblongata and controls the heart,
lungs and the digestive tract 11. Secondly, cell bodies in the lateral grey horn of the spinal cord at
the level of T12-L1, which then exit the spinal cord at S2-S4. The preganglionic neurons release
acetylcholine at both the ganglion synapses and the postsynaptic terminals 12. Postganglionic fibres
in the PNS are shorter than in the SNS. This system acts to slow bodily functions and is primarily
used during times of rest and digestion.

The SNS and PNS function primarily through autonomic reflexes. The baroreflex is extremely
important in the control of regulating arterial BP

11

. The receptors responsible for measuring

changes in BP are found in the aortic arch and the carotid sinus. These receptors relay information
to the central nervous system. When BP decreases the baroreceptors are activated and cause an
increase in excitatory input to the preganglionic sympathetic neurons, which in turn produces an
increase in BP. This type of reflex is activated anytime BP drops, for example when an individual
stands up. Together these two systems function to control most involuntary mechanisms and work
to maintain homeostasis of the body 11.

Multiple studies have demonstrated that the PNS and the SNS are involved in cognitive
functioning 14,15. The PNS is responsible for regulating high frequency heart rate variability which
was associated with greater inhibitory cognitive control during the Eriksen flanker task in a study
of 56 participants

15

. A study found that individuals with greater hear rate variability had better

executive function than individuals with low heart rate variability. A link has been found between
the performance of a cognitive task and an increase in SNS activation 14. Therefore, damage to the
PNS or the SNS may result in altered cognitive functioning.

4

Figure 1. The Autonomic Nervous System 13
This diagram displays both the sympathetic and parasympathetic divisions of the ANS. The SNS
originates at T1-L2 and the PNS originates at CN III, VII, IX, and X and S2-S4. Each division
innervates specific target organs.
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2.2

Autonomic Dysfunction

Any main system of the human body can suffer from dysfunction including the ANS. Damage to
the ANS can occur from an autoimmune disease, diabetes, an infection, a side effect of medication,
an abnormal protein buildup, or an inherited disorder 16. Nerve damage interferes with the signals
communicating between the brain and the effector organ. Consequently, severe symptoms can
arise in the presence of autonomic dysfunction since the ANS controls many vital bodily functions.
Autonomic dysfunction can present with a variety of symptoms, including irregularities with
sweating, inability to regulate heart rate, lightheadedness, dizziness, weakness, fatigue, urinary
problems, sexual dysfunction, and digestive issues. A common and debilitating symptom referred
to as orthostatic hypotension (OH) can occur in individuals with autonomic dysfunction. OH is
characterized by a profound drop in systolic blood pressure (SBP) of ≥ 20mmHg or diastolic blood
pressure (DBP) of ≥ 10mmHg within three minutes of upright posture. OH can be triggered by
either a nonneurogenic or a neurogenic cause. Nonneurogenic OH can be caused by hypovolemia,
cardiac pump failure, venous pooling and some medications 17. Nonneurogenic OH can sometimes
be resolved by increasing fluid intake, increasing salt intake, wearing compression stockings or an
abdominal binder. Neurogenic orthostatic hypotension usually has no cure and often results from
permanent damage to the ANS.

A large array of diseases and disorders are related to autonomic dysfunction. Some common
conditions include Parkinson’s disease (PD), lewy body dementia (LBD), pure autonomic failure
(PAF), multiple systems atrophy (MSA), primary amyloidosis and diabetic neuropathy. These
diseases present with different clinical features, for example PD can present with a tremor, LBD
can present with cognitive problems, but most will also present with the symptom of OH.
Autonomic dysfunction develops early in patients with MSA, PAF and LBD thus OH is normally
the most prominent clinical feature. Parkinson’s disease can also present with autonomic
dysfunction, but it normally presents later in the disease. Up to 58% of PD patients will experience
autonomic failure 18 .

6

2.3

Neurogenic Orthostatic Hypotension (NOH)

Neurogenic orthostatic hypotension (NOH) is a hallmark feature of autonomic failure

19

. NOH

occurs secondary to either neuropathy of the peripheral nervous system or to a central nervous
system lesion 20. It is most commonly found in the elderly population 21. NOH is characterized by
a severe drop in systolic blood pressure (SBP) ≥ 20mmHg or diastolic blood pressure (DBP) ≥
10mmHg within three minutes of standing up or HUT 22.

NOH is associated with autonomic degenerative disorders such as PD, MSA, LBD, and PAF. It is
also associated with peripheral neuropathies such as Guillain Barre syndrome, diabetic neuropathy,
hereditary amyloidosis, and familial dysautonomia 21. NOH is a common symptom related to these
diseases since BP regulation is often affected when the ANS is damaged.

When a healthy individual changes position from sitting to standing, the effect of gravity causes a
shift of approximately 500-1000ml of blood into the lower extremities 23. Pooling of blood in the
lower body results in decreased venous return, which causes decreased cardiac output and a
reduction in postural BP. The baroreflex response then acts to increase peripheral resistance,
venous return to the heart and cardiac output

23

. Consequently, there is very little change in

systemic BP since the baroreflex activation is immediate. Individuals with NOH have an impaired
BP and HR response to standing due to baroreflex failure. The sympathetic vasomotor neurons do
not release an adequate amount of norepinephrine to produce suitable peripheral vasoconstriction.
Without vasoconstriction blood pools in the lower extremities resulting in a BP drop 21.

NOH patients experience a variety of symptoms during an orthostatic challenge; the most common
being lightheadedness, dizziness, weakness, fatigue, and difficulty thinking. Symptoms tend to
worsen with specific stressors. These stressors include; standing up in the morning after being
supine for a long duration, hot weather/ hot shower or bath which cause cutaneous vasodilatation,
after eating a large meal which causes splanchnic vasodilatation, during prolonged standing which

7

can cause BP to continually decease, coughing since it increases intrathoracic pressure which
further decreases venous return to heart 24. Symptomatic NOH can be severely disabling, increase
the risk for injurious falls, and decrease quality of life 25.

Diagnostic Tests for NOH

2.4

When diagnosing NOH, a clinician will take into consideration a medical history, neurological
examination and a standardized autonomic reflect screen (ARS). The ARS is a validated tool that
consists of four tests which assess the integrity of the ANS 26. The function of both the sympathetic
and parasympathetic nervous system can be evaluated using the ARS. Each test is described in
depth below.

2.4.1

Quantitative Sudomotor Axon Reflex Test (QSART)

The human sweat glands are regulated by postganglionic sympathetic sudomotor axons 27. When
acetylcholine is released from the axon terminals it causes a sweat response to occur. QSART
assesses the sweat function of four postganglionic nerves; ulnar, peroneal, saphenous and sural. A
multicompartmental sweat cell is placed over each one of the four nerves and secured in place with
a rubber strap. Ground electrodes are positioned beside each sweat cell. The placement of each
sweat cell is as follows; forearm between the ulnar epicondyle and the pisiform bone, proximal leg
5 cm distal to the fibular head, distal leg 5 cm proximal to the medial malleolus, and dorsum of
the foot over the extensor digitorum brevis muscle 28. The sweat cell has an outer ring where the
acetylcholine gel is located and an inner compartment from which the sweat response is recorded.
Five minutes of constant anodal current iontophoresis of 10% acetylcholine at an intensity of 2mA
is used to stimulate the sudomotor axons. The 2mA current causes the release of the acetylcholine
from the multicompartmental sweat cell, which activates the sweat response. After the stimulation
is turned off an additional five minutes is recorded. Sweat volumes are recorded for the total
duration of the test.

8

A normal test (Figure 2A) displays sweat volumes above the lower limit which is as follows 0.122,
0.160, 0.079, and 0.102uL for forearm, proximal leg, distal leg, and foot respectively. Whereas,
irregular tests (Figure 2B) can show significantly reduced (i.e. hypohidrosis) or increased (i.e.
hyperhidrosis) sweat volumes. Individuals with peripheral neuropathy are likely to have a length
dependent reduction in sweat volumes, thus the most reduced volumes are located the most
distally. Irregular test results can indicate damage to the postganglionic axons in the SNS

26

.

Healthy Individual

A)

NOH Patient

B)

Figure 2. QSART in A) Healthy Individual and B) NOH Patient
Each line represents one of the 4 sites tested. Red line: forearm, blue line: proximal leg, green line:
distal leg, and yellow line: foot. The purple arrows indicate when the electrical stimulation started
and ended. Graph A shows a normal response to QSART, whereas graph B shows reduced sweat
volumes in a patient with NOH.

9

2.4.2

Heart Rate Variability to Deep Breathing

A deep breathing exercise can be used to assess cardiovagal function 26. A breathing frequency of
five seconds inspiration and five seconds expiration is used for eight consecutive cycles. To
accurately achieve this breathing frequency slow deep breaths are completed following a column
of green light, breathing in as the light goes up the column and breathing out as the green light is
going down the column. HR is recorded during this test to measure HR variability which analyzes
parasympathetic function.

In a healthy individual HR should increase during inspiration and decrease during expiration,
therefore large fluctuations in HR should occur with deep breathing, this can be seen in Figure 3A.
The lower limit for HR difference during deep breathing is 4.8bpm for males and 6.2bpm for
females. Impaired cardiovagal function is indicated by a HR variability below the lower limit.
NOH patients are a group of individuals who show very little HR variability during this test,
suggesting cardiovagal impairment, which can be seen in Figure 3B.

10

A)

Healthy Individual

SBP

HR

B)

NOH Patient

SBP

HR

Figure 3. Deep Breathing Task in A) Healthy Individual and B) NOH Patient
The deep breathing task is performed two times with a one-minute rest period between trials, the
start and end of each trial are indicated by the markers at the bottom of the graph. Graph A shows
large fluctuations in HR during deep breathing, whereas graph B shows almost no change in HR
during deep breathing.
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2.4.3

Valsalva Maneuver

The Valsalva maneuver (VM) is used to calculate a Valsalva ratio (VR) which is the maximum
HR achieved during the VM divided by the minimum HR occurring within 30 seconds of the
maximum HR. The maneuver requires the participant to blow into a mouthpiece to a pressure of
40mmHg and hold it at this pressure for 15 seconds. The maneuver produces a cascade of events;
there is a change in intrathoracic pressure which decreases venous return, there is a drop in BP,
activation of baroreflex, reflex tachycardia, and peripheral vasoconstriction 13. Monitoring beatto-beat BP changes during the maneuver allows for evaluation of the baroreflex function. The
lower limit of normal for the VR in males is 1.31 and in females is 1.3. If the VR is below this
limit, it can indicate impairment of cardiovagal function.

In a healthy individual the beat-to-beat BP response to this maneuver shows four distinct phases,
which are as follows: Phase I demonstrates an increase in BP due to increased intrathoracic and
intra-abdominal pressure which causes compression on the aorta, which reduces venous return.
Early Phase II shows a drop in BP due to the reduced venous return. This drop in BP activates
baroreflexes. Late Phase II shows an increase in BP back towards baseline BP (alpha-adrenergic).
Phase III occurs due to decreased in intrathoracic pressure, therefore BP decreases causing a burst
of sympathetic activity. Phase IV is represented by an overshoot in BP (beta-adrenergic)

13

.

Following this maneuver, the time it takes for both BP and HR return to resting values is measured.
This response is displayed in Figure 4A.

Individuals with NOH show a different beat-to-beat BP response to this maneuver, which is
displayed in Figure 4B. The beat-to-beat BP recording displays absent late phase II indicating an
impaired baroreflex response, therefore BP continues to drop. Phase IV overshoot is also absent
because there is no burst in sympathetic activity to cause a rapid increase in BP. Since NOH
patients experience very little change in HR during the VM a low VR will result.

12

A)

Healthy Individual

SBP

HR

B)

NOH Patient

SBP

HR

Figure 4. Valsalva Maneuver in A) Healthy Individual and B) NOH Patient
The Valsalva maneuver (VM) is performed two times, indicated by the markers at the bottom of
the graph. Graph A shows all 4 distinct phases of the VM and a large increase in HR, whereas
graph B shows an absent late phase II and phase IV overshoot and very little change in HR.
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2.4.4

Head-Up Tilt

Head-up tilt (HUT) is one of the most important tests when diagnosing NOH. HUT assesses
adrenergic function during an orthostatic challenge. The patient is positioned on a tilt table in the
supine position with their feet flat against a footboard. HR is measured using an
electrocardiography device and BP is measured with a beat-to-beat BP monitor. These measures
are recorded in the supine position for one minute to determine resting HR and BP. Following oneminute baseline, the bed is tilted to 70 degrees upright and remains in this position for five minutes,
the table is then tilted back down to the supine position and an additional five minutes of recovery
is recorded 26.

This test simulates standing and allows the natural force of gravity to act on the body which causes
a shift of blood volume into the lower limbs. A healthy individual will have very little change in
BP and HR during HUT since the ANS activates a response to increase vasoconstriction which
maintains BP at a normal level, which can be seen in Figure 5A. If a slight drop in BP occurs
during HUT HR will increase slightly to compensate for the BP decrease.

Individuals with NOH experience a significant drop in BP within 2-3 minutes of HUT (Figure 5B).
BP will drop at least 20/10mmHg with little to no change in baseline HR. This large drop in BP
with no compensatory postural tachycardia indicates autonomic dysfunction. Damage to the
sympathetic nerves causes insufficient vasoconstriction therefore, blood continues to pool in the
lower extremities. Consequently, BP remains reduced for the whole duration of an orthostatic
challenge. When standing, some patients feel severe symptoms of lightheadedness, dizziness,
weakness, and/or fatigue, whereas some patients are asymptomatic. Symptoms are often dependent
upon how large the drop in BP is and if the patient’s body has adapted to this drop. When the tilt
table is returned to the supine position BP will increase back to baseline.
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A)

Healthy Individual

SBP

HR

B)

NOH Patient

SBP

HR

Figure 5. Head-up Tilt in A) Healthy Individual and B) NOH Patient
Initiation of head-up tilt occurs at the first marker at the bottom of the graph and the table is
returned to the supine position at the second marker. Graph A shows very little change in SBP and
a slight increase in HR during HUT, whereas graph B shows a severe drop in SBP and a very small
change in HR during HUT.
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Treatment of NOH

2.5

There is currently no cure for NOH, therefore treatment can be used to reduce the associated
symptoms. Decreasing the occurrence of symptoms improves the quality of life of the patients.
Both non-pharmacological and pharmacological interventions can be used to help treat symptoms.

2.5.1

Non-pharmacological Treatment

Non-pharmacological interventions can be used to reduce the occurrence and severity of symptoms
associated with low BP. Both increased fluid intake and increased salt intake can help raise overall
BP. It has been advised that NOH patients should consume 2 to 2.5 L of water per day 17. During
activities in the upright position wearing an abdominal binder can assist in increasing venous return
which may reduce the drop in BP. Patients should be instructed to consume small meals since large
meals containing a high carbohydrate content cause splanchnic vasodilatation. Activities that raise
core body temperature should be avoided such as exercising on hot days, hot showers/baths, and
saunas since they cause skin vasodilatation and NOH patients have impaired vasoconstriction. If
safe, patients should be instructed to complete lower body strength training, this will help maintain
lower limb muscle pumps to push blood back to the heart it will also prevent deconditioning.
Patients should be instructed to avoid straining and coughing since these maneuvers cause a drop
in BP. To ensure BP is not too high when lying down the head of the bed should be tilted up when
sleeping. These simple strategies can help reduce the burden of symptoms

29

. If these non-

pharmacological measures do not improve symptoms pharmacological measures can be
implemented.

2.5.2

Pharmacological Treatment

Pharmacological treatments are implemented to increase BP during times of low BP.
Florocortisone is used at a dose of 0.05 to 0.2 mg daily to help retain sodium and water

24

.

Midodrine is an α1 agonist used at a dose of 2.5 to 5 mg once to twice daily to induce
vasoconstriction 23. Pyridostigmine can be used with a dose of 60 mg twice to three times per day
or long acting forms 180 mg daily 28. Pyridostigmine inhibits acetylcholinesterase in preganglionic
16

sympathetic neurons therefore increasing sympathetic traffic 24. It also has a much milder affect
on BP than midodrine and fludrocortisone.

2.6

Cerebral Hemodynamics

Monitoring cerebral hemodynamics in healthy individuals gives insight about natural cerebral
blood flow changes that occur with aging. Between the ages of 20-70 there is a continual decline
in cerebral blood flow velocity (CBFv) in the basal arteries 30. Aging affects both cerebral blood
flow and cerebral vasculature 31. Cerebral autoregulation is a mechanism used to ensure the brain
is receiving adequate blood supply despite changes in systemic BP 32. This mechanism works by
rapidly adjusting cerebrovascular resistance and compensating for fluctuations in cerebral
perfusion pressure 33. It is a protective mechanism and prevents against brain ischemia when BP
is low and capillary damage when BP is high

34

. Severe changes in BP can cause disruption to

cerebral blood flow if SBP is outside of the autoregulation range (approximately ~80-160mmHg
in healthy individuals) 35. NOH patients experience significant fluctuations in SBP, therefore it is
important to identify if they have alterations in cerebral blood supply. Common techniques used
to measure cerebral blood supply are transcranial doppler and near infrared spectroscopy.

2.7

Transcranial Doppler

Transcranial Doppler (TCD) is a non-invasive ultrasound technique used to measure real-time
cerebral blood flow velocity (CBFv). TCD emits ultrasound waves from a probe at a frequency of
2MHz which penetrate through the skull and are reflected by moving red blood cells 36. A term
referred to as the Doppler shift frequency is the difference in frequency between the emitted and
reflected waves, which is proportional to the speed of moving red blood cells

36

. The middle

cerebral artery (MCA) is commonly used to measure CBFv since it is found near a thin region of
the skull referred to as the transtemporal window where the ultrasound waves can easily penetrate
through the skull. The MCA can be found with the probe set to a depth between 45 to 55mm. TCD
also measures pulsatility index, which provides information about the downstream cerebral
vascular resistance

37

. The pulsatility index is normally between 0.5 to 1.19
17

37

. A limitation of

TCD is that measures can not be obtained in about 10-15% of people. This occurs when individuals
have an inadequate transtemporal window due to the thickness and porosity of the bone near the
window

36

. The following formula describes the relationship between flow velocity (reflector

speed) and Doppler shift frequency

36

𝑐𝑚

: 𝑅𝑒𝑓𝑙𝑒𝑐𝑡𝑜𝑟 𝑠𝑝𝑒𝑒𝑑 ( 𝑠 ) =

(𝑑𝑜𝑝𝑝𝑙𝑒𝑟 𝑠ℎ𝑖𝑓𝑡)𝑋 𝑝𝑟𝑜𝑝𝑎𝑔𝑎𝑡𝑖𝑜𝑛 𝑠𝑝𝑒𝑒𝑑
2 𝑋 𝑖𝑛𝑐𝑖𝑑𝑒𝑛𝑡 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑋 𝑐𝑜𝑠𝜃

The doppler shift is the change in frequency of a wave in relation to an observer who is moving
relative to the wave source. The propagation speed is the speed of ultrasound in the tissue. The
incident frequency is the original frequency of the ultrasound. Theta (θ) is the angle of the emitted
wave relative to the direction of blood flow in the vessel 36.

The application of TCD can be used to monitor a variety of conditions such as vasospasm in sickle
cell disease, raised intracranial pressure, head injuries, subarachnoid hemorrhage, intra- and
extracranial arterial stenosis and occlusion, and intraoperative monitoring

37

. Monitoring CBFv

can provide important information about the clinical conditions listed. Alterations in CBFv also
occur when there are drastic changes in systemic BP 9. Accordingly, it is beneficial to measure
CBFv in NOH patients since they are a population who experience large fluctuations in BP.

2.8

Near Infrared Spectroscopy

Near infrared spectroscopy (NIRS) is a non-invasive technique used to measure regional cerebral
oxygen saturation (rSO2) using light wavelengths between 700-1000nm. NIRS is placed bilaterally
on the forehead to measure rSO2 in the frontal lobes. The wavelengths are able to pass through the
skull to reach the cortical tissue 38. Oxygen uptake is calculated by the difference in oxyhemoglobin
and deoxyhemoglobin. rSO2 provides insight about the oxygen supply the brain is receiving.
Normal rSO2 values range from 60-80% 39.
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rSO2 will vary depending on how much oxygen the brain requires. rSO2 increases when the
metabolic activity of neurons rises so that the metabolic demands can be met

40

. For example,

when a brain region is functionally activated there will be an increased metabolic demand. A
decrease in systemic BP has been linked to a decrease in rSO2. A decrease in blood flow can affect
oxygen delivery to the brain tissues being measured

39

. Therefore, rSO2 should be monitored in

patients with NOH.

2.9

Cerebral Hemodynamics &Autonomic Dysfunction

Adequate cerebral blood supply is important for physical and cognitive functioning. Monitoring
cerebral hemodynamics in patients with autonomic dysfunction is beneficial to determine if the
brain is receiving an adequate blood supply since this population can suffer from cerebral
hypoperfusion. Substantial evidence suggests that cerebral hypoperfusion contributes to cognitive
dysfunction 41. Multiple studies have assessed cerebral hemodynamics in patients with autonomic
dysfunction but the mechanisms altering cerebral perfusion are not completely understood 42.

As mentioned individuals with autonomic dysfunction lack the ability to control vascular tone
when standing, therefore they are unable to increase systemic vascular resistance 43. Consequently,
blood supply to the brain may be reduced in the upright position. Multiple studies have assessed
cerebral hemodynamics in both the supine and standing positions in patients with autonomic
dysfunction

32,43,44

. A prior study assessed 8 patients with PAF and 1 patient with MSA who

experienced a significant decrease in BP upon standing. Findings demonstrated that supine CBFv
was higher in patients than controls and upon standing CBFv decreased significantly in the patient
group. In the standing position rSO2 also decreased more in the patient group than the controls 43.
A separate study assessing cerebral hemodynamics in 7 MSA patients and 9 controls found that
during HUT, MSA patients had a greater decrease in mean arterial pressure (MAP) at the level of
the skull than controls. During HUT, there was also a reduction in cerebral oxygenation in MSA
patients and controls, but no significant difference between groups 32. Cerebral oxygenation was
investigated in 18 patients with autonomic failure (AF) and 10 healthy controls in both the supine
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and HUT positions. Results demonstrated that during HUT, MAP increased in the controls by
12.3mmHg and decreased in the patients by -46.7mmHg. During HUT, the control group had a
small reduction in rSO2 by -0.5% whereas the patient group had a significant decrease by -8.5%
44

. These studies revealed that an orthostatic stress can cause a reduction in CBFv and rSO2 in

patients with autonomic dysfunction.

When assessing rSO2 in 19 MSA patients and 10 healthy controls it was found that during HUT
presyncopal patients experienced a significantly larger decrease in rSO2 (-3.1 ± 1.7%) than non
pre-syncopal patients (-0.9 ± 0.5%) and controls (-1.1 ± 1.0%). These results demonstrated that
the reduction in rSO2 was related to orthostatic symptoms. During HUT most of the presyncopal
MSA patients had SBP readings below 80mmHg and had rSO2 values below 70%. Accordingly,
when SBP is extremely low, cerebral autoregulation may not be as effective 8. Patients are more
likely to experience symptoms when they are outside the autoregulated range of 80-160mmHg 35.
When BP drops individuals with PAF exhibited symptoms of cerebral hypoperfusion. These
individuals had reduced rSO2 measures compared to controls

45

. Cerebral blood flow was

investigated in 7 women with OH. During HUT, there was a decrease in mean hemispheric blood
flow compared to supine. During HUT, there was also a redistribution of blood flow, with an
increase in the postcentral areas and a decrease in the frontal area 46. It is evident that changes in
both CBFv and rSO2 occur in patients with autonomic dysfunction during an orthostatic challenge
due to a postural reduction in systemic BP. Even in healthy individuals a drop in cerebral perfusion
has been identified upon standing since cerebral autoregulation is unable to immediately
compensate for the initial drop in BP that results from the gravitational blood pooling upon
standing 47. This decrease in rSO2 is extremely short lived and lasts for only seconds in healthy
individuals. Whereas, NOH patients can have a reduction in rSO2 that lasts the entire duration of
standing.

Literature specifically related to NOH patients and changes in cerebral blood flow is limited. A
study revealed that in the standing position NOH patients had transient cerebral hypoperfusion and
upon returning to the supine position cerebral blood flow returned to normal

20

48

. Consequently,

continuous exposure to repeated cerebral hypoperfusion may endure brain changes that could lead
to accelerated cognitive decline

48,49

. Prior research has speculated a link between cerebral

hypoperfusion and deficits in short-term memory, abstract thinking, visual memory, and attention
50

. There are few studies specifically related to patients who experience cerebral hypoperfusion

and how it could be related to changes in cognitive function, therefore further investigation on this
topic is necessary.

Normal Aging and Cognitive Decline

2.10

The process of natural aging causes changes in brain structure including a reduction in total brain
volume 31, cortical thinning, white-matter degradation 51, and alterations in synaptic connectivity
52

. Brain volume decreases by about 5% per decade after the age of 50 53, particularly the frontal

lobes

31

. A review examining MRI scans found that prefrontal cortex (PFC) volume had the

greatest atrophy in older adults 53. The PFC is also affected by molecular changes which correlate
with aging

54

. MRI can be used to measure the thickness of the cerebral cortex to investigate

cortical thinning. Studies have found that cortical thinning occurs by middle age and affects a
widespread cortical area that continues to thin with aging 55. White matter loss also occurs with
aging. The development of white matter hyperintensities and hippocampal volume loss are a
natural process of aging

56

. A study investigating rhesus monkeys found that aging causes a

significant overall loss of synapses in prefrontal area 46

57

. These alterations in brain structure

have been related to an increased rate of cognitive decline. The aging brain has differences in both
structure and function which are associated with cognitive decline 51.

These structural changes related to aging come with severe consequences to cognitive function.
Aging is associated with a decline in memory, spatial visualization, information processing speed,
attention, executive functioning, and conceptual reasoning

1,2

. As previously mentioned, aging

causes PFC atrophy. The PFC is one of the most important areas involved in cognitive control and
is responsible for executive functioning 58. The PFC is heavily relied upon to accurately perform
cognitive tasks such as the Stroop test which involves selective attention 59.
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Cognitive Decline Associated with Disease

2.11

Some diseases and conditions are associated with decreased cognitive functioning. Alzheimer's
disease (AD) and LBD accelerate the progression of brain atrophy and cognitive decline

60

.

Individuals with AD experience the fastest rate of decline in attention, visuo-spatial and executive
functions compared to other cognitive functions 6. A stroke can also result in changes in cognitive
function. A study investigating IPS post-stroke and its effect on cognitive function found that
stroke patients performed significantly worse in all cognitive domains compared to healthy
controls. Processing speed was significantly reduced in 90% of stroke patients demonstrated by
poor Symbol Digit Modalities Test scores

61

. Total white matter hyper-intensity volume is also

significantly related to slower IPS 56. Traumatic brain injury can also result in decreased cognitive
functioning. Patients who suffered from a traumatic brain injury had reduced IPS and attentional
difficulties

62

. A review found that long-term cognitive impairment occurred in about 50% of

individuals with a single traumatic brain injury 63. A multitude of reasons can contribute to the
accelerated rate of cognitive decline therefore, investigation is needed to determine exactly what
is triggering the decline in cognitive functioning. It is important to be able to distinguish between
normal cognitive decline and accelerated cognitive decline as a result of disease.

Neurological diseases can affect important cognitive domains such as IPS and attention. IPS is a
measure of the time between receiving a stimulus and responding to a stimulus
processing is an essential component of cognitive functioning

2, 65

64

. This type of

. A decline in IPS can affect

many cognitive domains, such as verbal fluency, attention, visuospatial function, memory, and
executive function. Multiple sclerosis (MS) is a neurological disease that often presents with a
decline in IPS. This decline is one of the first cognitive deficits to surface in MS patients

66

.A

study used neuropsychological tests to assess IPS in MS patients during times of relapse and
recovery. Results showed that during time of relapse MS patients had significantly worse SDMT
scores indicating slower IPS

67

. This finding is common among other studies investigating

cognitive function in MS patients 68. If, IPS is reduced early in disease progression in MS patients,
it may also be reduced early in other neurodegenerative conditions.
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Cognitive performance has been assessed in individuals with mild cognitive impairment (MCI)
and those with MCI and OH. The individuals with OH had reduced processing speed and visual
working memory compared to the group without OH. It was found that a higher prevalence of OH
was correlated with the severity of cognitive status 7. A cohort of 4690 participants aged 50 plus
were examined to determine the relationship between supine hypertension, OH, and cognitive
performance. Results revealed that individuals with supine hypertension combined with OH had
poorer global cognition and executive function than individuals with only supine hypertension

69

.

A relationship between cognitive impairment and OH has also been established in patients with
α-synucleinopathies which includes PD, LBD and MSA. It is believed that the presence of αsynuclein could be contributing to both OH and cognitive impairment or the hypoperfusion
resulting from OH is impairing cognition 5.

2.12

Cognitive Function and its Relationship to NOH

The prevalence of NOH increases with age and is commonly diagnosed in the elderly population
which is also the population at risk for normal cognitive decline 21. Consequently, there may be a
relationship between NOH and changes in cognitive function. NOH patients can suffer from ANS
damage, hypotension, cerebral hypoperfusion and fatigue

70

. These symptoms could be factors

influencing the decline in cognitive functioning. Prior research has stated that NOH and cognitive
decline could be related since the brain regions involved in both are responsible for cardiovascular
autonomic processes and cognitive control 49. NOH patients frequently complain about difficulty
concentrating and thinking

71

. Consequently, cognitive function in NOH patients has been

investigated in a variety of ways, including assessing cognitive function in the supine, sitting, and
standing positions, as well as comparing cognitive function to healthy controls.

Baseline cognitive function is evaluated in the seated position to ensure cognitive performance is
not affected by a positional change in BP. Fourteen patients with PAF with a postural SBP drop
of at least 20mmHg underwent neuropsychological assessment in the seated position. Patients
presented with significant deficits in speed, attention and executive functioning. These deficits
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were found in both patients with and without white matter lesions, therefore the lesion was not the
only cause of cognitive impairment 72. In a sample of 5,963 individuals aged 50 plus, 6.3% had
OH. Participants with OH had significantly worse global cognitive function, processing speed,
sustained attention, and memory compared to participants without OH 73. Therefore, OH may be
contributing to changes in cognitive functioning.

Previous literature has demonstrated that OH causes an increased risk of developing cognitive
impairment. At a 4 year follow up the incidence of cognitive impairment was significantly greater
in OH individuals (23.7%) than a control group (9.2%) 74. OH patients who had a significant drop
in SBP while standing had worse verbal memory, global cognition and scanning and tracking
scores than those without OH

75

. A study found that the prevalence of OH correlated with the

severity of cognitive deficits. The group of individuals with OH and MCI presented with
significantly reduced processing speed, working memory and executive functions 7.

When assessing cognitive function during an orthostatic challenge such as HUT it was found that
NOH patients experienced a significant drop in SBP of at least 20 mmHg and had significantly
worse global and executive cognitive performances

76

. A study assessed cognitive function in a

variety of different positions in 12 patients with PAF or autoimmune autonomic neuropathy and
12 control subjects. Findings revealed that in the seated position global cognitive function was
preserved but during HUT the patients had a significant decrease in immediate memory, working
memory, abstract thinking, and sustained attention compared to controls

77

. Neuropsychological

assessment was used to evaluate cognitive function in both the supine and HUT positions in 10
NOH patients. During HUT, NOH patients experienced a significant worsening in executive
functioning, including a decrease in global cognitive functioning and specific tasks compared to
the supine position 78. Overall, a significant difference in cognitive function between the supine
and HUT positions has found been found in patients who experience NOH.
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2.13

Cognitive Tests

There are many neuropsychological assessments available to evaluate cognitive function. When
selecting which cognitive assessments to administer it is important to consider the population being
assessed, length and ease of administration, established norms, and reliability of the assessment.
Prior research has stated that a decline in IPS is one of the first cognitive deficits to surface in MS
patients 66, therefore a reduction in IPS may arise early in other neurological conditions such as
NOH. Individuals with NOH struggle to remain in the standing position for an extended period of
time since BP drops in this position. Therefore, when selecting tests to assess cognitive function
in this population it is important to ensure the tests are short in duration if assessing patients in the
upright position.

2.13.1

Symbol Digit Modalities Test

The symbol digit modalities test (SDMT) is a paper based neuropsychological test used primarily
to assess IPS. A sheet of paper has a key at the top with the numbers 1 to 9, each number has a
corresponding symbol above. Beneath the key there are eight rows of symbols with each row
consisting of 15 symbols 79. In the oral version, the participant has 90 seconds to say out loud what
number correctly corresponds with each symbol. The number of correct responses and the number
of errors are recorded.

The SDMT is a validated test and is widely accepted as an accurate measure of IPS 80. The SDMT
was originally administered in a written format where the participant would write down the
corresponding number that matched with the symbol. The oral version of the SDMT is beneficial
because it does not require motor movement, which is necessary for the written version. The oral
SDMT displayed strong positive correlations (r = 0.78 to 0.82) with the written SDMT in healthy
adults. The oral SDMT was proven to be reliable over multiple test-retest intervals over a 48-week
period, had a test-retest reliability coefficient of 0.76 in healthy adults and had an excellent testretest reliability coefficient of 0.89 in a group of stroke patients 81–83. Therefore, the oral version
is a reliable way to measure IPS.
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It has been stated that the SDMT was the best test to predict cognitive impairment in a sample of
MS patients. 75.4% of the patients were correctly classified 84. SDMT is significantly associated
with age, gender, cultural background, and level of education 85, therefore, these variables need to
be taken into consideration when analyzing SDMT scores. SDMT has been used to screen for and
diagnose cognitive impairment in MS patients. Even a small change in SDMT score by 3-4 points
is clinically meaningful 67. Another advantage of the SDMT is that it only takes about 5 minutes
to complete the testing.

2.13.2

Stroop Test

The Stroop test is a neuropsychological test originally developed in 1935 by John Ridley Stroop
to measure attention and response inhibition 86. It can measure how well an individual is able to
inhibit a dominant response and respond to an unusual one

87

. It has been regarded as a gold

standard test to measure attention and is able to measure selective attention independently from
processing speed 88,89. The Stroop test requires the completion of three subtests which are each 45
seconds in duration. Each test is a sheet of paper containing 100 words of colours (i.e. blue, red,
purple, brown, green). The participant is instructed to say out loud as many words as possible in
the time given. The first subtest is referred to as the Word Stroop test (W). In this version the words
of colours are written in black ink. The second subtest is referred to as the Colour Stroop test (C)
and consists of words of colours written in the same colour of ink as the word. The participant
must say out loud the colour of the ink. The third subtest is referred to as the Colour-Word Stroop
test (CW). In this version the word of the colour and the colour of the ink that the word is printed
in do not correspond. For example, the word may say blue but be printed in red ink. In this task
the participant must say the colour of the ink and inhibit themselves from saying the word. The
correct number of responses and the number of errors for each subtest are recorded. The W test
and the C test are completed to obtain a baseline for comparison with the CW test.
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The most important information that can be obtained from the Stroop test is Golden’s interference
(Ig) score. The interference score represents the amount of delay the participant has in naming the
colour of the ink since they must inhibit themselves from saying the word. The interference score
can be calculated using the score achieved in the CW trial subtract a predicted colour-word (Pcw)
score. The CW score represents the amount of time it takes for an individual to identify the colour
of the ink plus the amount of time it takes to suppress the reading the word. A predicted colourword score is calculated based on how many correct answers were scored in the C trail and the W
trial. This gives an estimate of how well the participant should score on the CW version. The lower
the interference score, the worse the attention. The following equations are required to calculate
the Ig score: 𝑃𝑐𝑤 =

2.14

(𝑊𝑥 𝐶)
(𝑊+𝐶)

𝐼𝑔 = 𝐶𝑊 − 𝑃𝑐𝑤

Conclusion

Current literature investigating NOH patients, cerebral hemodynamics, and cognitive functioning
is limited, therefore future research related to this topic is necessary. When studying NOH patients,
it is crucial to understand the physiology of the condition so that caution is taken when the patient
is in the upright position. It is important to measure HR, BP, CBFv, and rSO2 in NOH patients
since these measures can fluctuate with positional changes. As well, if testing cognitive function
in the supine and upright positions it is imperative to select tests that are short in duration so they
can be completed in the upright position.
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Chapter 3

3

Neurogenic orthostatic hypotension impairs information
processing speed and attention 1

3.1

Introduction

Neurogenic orthostatic hypotension (NOH) is a condition characterized by a reduction in systolic
blood pressure (SBP) ≥ 20mmHg or diastolic blood pressure (DBP) ≥ 10mmHg within three
minutes of upright posture 1. A sudden drop in BP can trigger symptoms such as lightheadedness,
dizziness, weakness and fatigue soon after standing up. These symptoms make simple daily
activities more challenging and increase the likelihood of falls 2.

NOH commonly occurs in the elderly population 3. This population is also at an increased risk for
cognitive decline; therefore, it is important to investigate if there is a relationship between NOH
and changes in cognitive function. Current literature focusing on NOH and cognitive function
investigates processing speed, attention, and executive function in the seated position but fails to
investigate cognition in the standing position 4. However, standing may be the time at which
impairment of cognitive function is the most severe due to associated hypotension. It is also the
time that affected individuals are at greater risk for complications from NOH such as falls.

It is well-known that with aging there are changes in cognitive function. Many cognitive abilities
decline with aging such as memory, spatial visualization, attention, information processing speed,

1

A version of this manuscript has been submitted for publication. Robinson, L., Kimpinski, K. Neurogenic
orthostatic hypotension impairs information processing speed and attention. Physiology & Behavior. 2019. Under
revision.
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and conceptual reasoning 5,6. Attention is the ability to attend to specific stimuli while inhibiting
attention to other stimuli, which is required for many everyday tasks 7. When an individual is
unable to focus on the relevant stimuli, interference from the irrelevant stimuli occurs. Interference
is commonly measured using the Stroop Test, where greater interference indicates worse attention.
The amount of interference from irrelevant information increases with aging 8, therefore older
individuals have a more difficult time inhibiting an undesired response. Information processing
speed (IPS) is the time between receiving a stimulus and responding to a stimulus 9. A common
neuropsychological test to measure IPS is the Symbol Digit Modalities Test (SDMT). IPS is linked
to higher cognitive functions

10

and, therefore, a decline in processing speed can affect other

cognitive domains. It has been stated that IPS is a predictor of the ability to perform simple daily
activities 11 and an indicator of independence 12. It was found that IPS was the first cognitive deficit
to surface in individuals with multiple sclerosis 13. Consequently, a deficit in IPS or attention may
also arise early on in other neurological conditions, such as NOH.

The objective of the current study was to investigate the potential changes in IPS and attention in
NOH patients in both the supine and head-up tilt (HUT) positions. In addition, the study’s further
objective was to describe the relationship between cognitive function and the potential change in
SBP in NOH patients.

It was hypothesized that NOH patients would experience a decline in IPS and attention in the HUT
position compared to the supine position due to the associated reduction in postural BP. Controls
would have an increase in IPS and attention in the HUT position compared to the supine position
since they experience a burst of sympathetic activity when they stand up. It was also hypothesized
that a greater drop in SBP during HUT would correspond with a worsening in IPS and attention.
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3.2
3.2.1

Methods
Participants

The current study enrolled 43 participants including 23 participants with a diagnosis of NOH and
20 healthy age-matched controls. The clinical diagnosis of NOH was provided by a neurologist
after evaluating the autonomic reflex screen (ARS) and a medical history. The criteria for NOH
was a drop in SBP ≥ 30 mmHg on HUT as it reduced the false positive rate from 5% to <1% when
compared to the ≥ 20/10 mmHg SBP/DBP criteria

14

. The conditions associated with NOH

included Parkinson’s disease (n=12), multiple system atrophy (n=4), pure autonomic failure (n=1)
and Lewy body dementia (n=1). Five participants had a diagnosis of idiopathic NOH.

Participants were excluded from the study if they had a medical history of coronary artery disease,
nerve damage in the peripheral nervous system, failure of other organ systems or diseases that
could affect autonomic function, visual problems, or the inability to remain in the upright position
for the duration of testing. All testing took place in the autonomic lab located at the University
Hospital in London, Ontario. All participants provided written informed consent before being
enrolled in the study. Ethical approval was obtained from the Health Science Research Ethics
Board at Western University.

3.2.2

Physiological Measures

Testing began with a standardized autonomic reflex screen (ARS). The ARS is comprised of four
tests; 1. quantitative sudomotor axon reflex test (QSART) to assess the quality of the
postganglionic sympathetic sudomotor axons, 2. deep breathing to assess cardiovagal function, 3.
Valsalva maneuver which allows for the calculation of a Valsalva ratio to assess cardiovagal and
adrenergic function and 4. HUT (table tilted to 70 degrees), which measures heart rate (HR) and
BP responses to an orthostatic challenge to assess adrenergic function 15.
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HR was measured using an electrocardiography device (Model 3000 Cardiac Trigger Monitor,
IVY Biomedical Systems, Inc., Branford, CT) connected to electrocardiography electrodes
(Ambu® Blue Sensor SP, Glen Burnie, MD). A beat-to-beat BP monitor (BMEYE Nexfin device,
Amsterdam, Netherlands) was secured on the middle finger. All recordings were made using WR
TestWorks TM software (WR Medical Electronics Co., Stillwater, MN).

3.2.3

Cognitive Measures

Cognitive function was assessed with two paper based neuropsychological tests; the oral version
of the Symbol Digit Modalities Test (SDMT) and the Stroop test. SDMT was used to assess IPS.
SDMT provides a key at the top of the page that has numbers 1 to 9 and each number corresponds
with a symbol. Underneath the key there are 8 rows of symbols and each row consists of 15
symbols. Each participant had 90 seconds to say aloud what number corresponds with each
symbol. The correct number of responses and the number of errors were recorded.

The Stroop test was used to measure attention. It consists of three different versions; each version
is a sheet of paper containing 100 words of colours (i.e. blue, red, purple, brown, green). Each
participant had 45 seconds to say aloud as many words as possible. The first version consists of
words of colours written in black ink. The second version consists of the words of the colours
printed in the same ink colour as the word. For example, the word “blue” is printed in blue ink. In
the third version, the word and the ink colour that the word is printed in do not correspond. For
example, the word “blue” could be printed in red ink. The participant must say the colour of the
ink and inhibit themselves from saying the word. The number of correct responses and the number
of errors were recorded for each version. The correct number of responses in each version was
used to calculate Golden’s interference score which represents attention 16

Prior to cognitive testing 90 seconds in the supine position was recorded to measure baseline HR
and SBP. The order of cognitive testing in the supine position was as follows; SDMT, Stroop 1,
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SDMT, Stroop 2, SDMT, Stroop 3, SDMT. The bed was then tilted to an angle of 70 degrees
(HUT) and 90 seconds of HR and SBP were recorded in this position before beginning the
cognitive testing. The order of the cognitive testing in the HUT position was as follows; Stroop 1,
Stroop 2, Stroop 3, SDMT. The bed was then tilted back to the supine position and the participant
completed 5 minutes of recovery to allow HR and BP to return to resting values.

The Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA)
were used to screen for significant pre-existing cognitive impairment. Both questionnaires are
scored out of 30 points and assess a variety of cognitive functions such as visuospatial, executive,
memory, attention, language, orientation, and delayed recall. A normal score on MMSE is a score
≥ 24 and ≥ 26 on the MoCA. A score lower than these values indicates cognitive impairment.

3.2.4

Statistical Analysis

Independent t-tests were used to compare characteristics such as HR, BP, age, BMI, MMSE and
MoCA scores between groups. A two-way mixed ANOVA was used to compared cognitive testing
between NOH patients and controls in both the supine and HUT positions. A Bonferroni post hoc
test was used to compare within group effects for both positions. Results are presented in mean ±
SD. A minimum significance level of p < 0.05 was used. The statistical analysis was performed
using SPSS statistics software, Version 25, Manufactured by International Business Management
(IBM) Corporation.

3.3
3.3.1

Results
Participants

A total of 40 participants completed the study, 20 control subjects and 20 NOH patients. Three
NOH patients were excluded because they were unable to remain in the upright position for the
duration of testing, consequently they were unable to complete the cognitive testing. Controls and
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NOH patients were matched based on age, BMI, and education level. The NOH group had fewer
females and more males than the control group, but no significant differences were found based
on gender. NOH patients had significantly lower MoCA and MMSE scores (Table 1).

3.3.2

Hemodynamic Measurements

Hemodynamic measures are presented in Table 2. Resting HR, resting SBP, and the change in HR
were not statistically different between groups. NOH patients had significantly lower scores for
heart rate variability during the deep breathing task and Valsalva ratio (VR) indicating cardiovagal
impairment 17. The change in SBP during HUT was significantly different between groups. The
drop in SBP during HUT was significantly greater in the NOH patients (-64.11 ± 18.96) compared
to the control group (-5.69 ± 7.65).

Table 1. Participant Characteristics

Characteristic

Control
(mean ± SD)

NOH
(mean ± SD)

Age (years)

64.50 ± 9.25

69.55 ± 7.43

Gender (F:M)

12:8

8:12

BMI (kg/m2)

21.50 ± 2.51

22.02 ± 4.71

16

13

MMSE Score

29.80 ± 0.41

28.74 ± 1.37 *

MoCA Score

28.60 ± 1.54

26.53 ± 2.37 *

Education Level (>high school)

BMI: body mass index, MMSE: Mini Mental State Examination, MoCA: Montreal Cognitive
Assessment. * Represents significant difference of p < 0.01
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Table 2. Physiological Characteristics

Characteristic

Control
(mean ± SD)

NOH
(mean ± SD)

Resting HR (bpm)

69.49 ± 11.91

74.28 ± 12.85

Change in HR during HUT (bpm)

15.04 ± 6.27

12.12 ± 8.60

128.12 ± 18.75

139.50 ± 23.72

Change in SBP during HUT (mmHg)

-5.69 ± 7.65

-64.11 ± 18.96 **

Heart Rate Variability (bpm)

14.47 ± 6.96

4.48 ± 2.67 **

Valsalva Ratio

1.74 ± 0.33

1.29 ± 0.18 **

Resting SBP (mmHg)

HR: heart rate, SBP: systolic blood pressure, HUT: head-up tilt, bpm: beats per minute, mmHg:
millimeters of mercury, ** Represents significant difference of p < 0.001
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3.3.3

Symbol Digit Modalities Test Scores

Mean SDMT scores in the supine and HUT positions are displayed in Figure 6. IPS was
significantly slower in NOH patients in both the supine (p < 0.001) and HUT (p < 0.001) positions
compared to controls. Controls had significantly faster IPS during HUT demonstrated by a mean
SDMT score of 69.90 ± 12.02 compared to a supine score of 63.55 ± 9.96 (p < 0.001). Whereas,
the NOH group had no statistical difference in IPS between the supine position 43.20 ± 15.26 and
the HUT position 42.90 ± 14.33 (p = 0.77).

3.3.4

Stroop Test Scores

The mean interference scores calculated from the Stroop test are displayed in Figure 7. A more
negative score represents worse attention, whereas a score closer to 0 represents better attention.
Controls had significantly better attention during HUT (-8.68 ± 7.13) compared to the supine
position (-14.01 ± 8.96; p <0.001). In contrast, NOH patients had no statistical difference in
attention between the supine and HUT positions (p = 0.11). During HUT, the mean interference
score was significantly worse in NOH patients (-14.86 ± 8.96) compared to controls (-8.68 ± 7.13;
p = 0.029).

3.3.5

Correlation between Blood Pressure & Cognitive Testing

Figure 8 shows no significant correlation between the change in SBP and SDMT score in NOH
patients (r = 0.284; p = 0.225) or controls (r = 0.293; p = 0.21). Figure 9 shows no significant
correlation between the change in SBP during HUT and interference score in NOH patients
(r = -0.147; p = 0.573) or controls (r = 0.078; p = 0.745). NOH patients experienced a significant
drop in SBP during HUT, but this drop did not relate to IPS or attention.
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c
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Figure 6. Mean SDMT Scores in the Supine and HUT Positions
Information processing speed (IPS) is represented by the mean SDMT score. NOH patients had
significantly slower IPS than controls in the supine and HUT positions. Controls had significantly
faster IPS in the HUT position compared to supine. NOH: neurogenic orthostatic hypotension,
CON: control, HUT: head-up tilt, SDMT: symbol digit modalities test; a: p < 0.001, between CON
and NOH in the supine position; b: p < 0.001, between CON and NOH in the HUT position; c: p
< 0.001, between supine and HUT position in CON.

45

a
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Figure 7. Stroop Test Scores in the Supine and HUT Positions
The Stroop test provides a mean interference score which represents attention. An interference
score closer to 0 represents better attention whereas a more negative score represents worse
attention. Controls had better attention in the HUT position compared to supine. NOH patients had
significantly worse attention in the HUT position compared to controls. NOH: neurogenic
orthostatic hypotension, CON: control, HUT: head-up tilt; a: p < 0.001, between supine and HUT
positions in CON; b: p = 0.029, between CON and NOH in HUT position.
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Change in SBP (mmHg)

r = 0.293

r = 0.284

SDMT Score

Figure 8. The Relationship Between SBP and SDMT Scores

There was no significant correlation between the change in SBP and SDMT score in NOH patients
(p = 0.225) or controls (p = 0.21). NOH: neurogenic orthostatic hypotension, CON: control, HUT:
head-up tilt, SDMT: symbol digit modalities test.
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Change in SBP (mmHg)

r = 0.078

r = -0.147

Interference Score

Figure 9. The Relationship Between SBP and Interference Scores

No significant correlation was found between the change in SBP and interference scores in NOH
patients (p = 0.573) or controls (p = 0.745). NOH: neurogenic orthostatic hypotension, CON:
control, HUT: head-up tilt.
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3.3.6

MMSE and MoCA Scores

An additional analysis was completed excluding all participants with MMSE scores <24 and
MoCA scores <26 to assess for the potential differences in underlying cognitive status between
groups to influence the results related to IPS and attention. This resulted in the exclusion of 1
control subject and 5 NOH patients. Of note, the control subject had a MoCA score of 25 and an
MMSE score of 29 and as such we did not feel elimination of this patient from the control group
during the original analysis was warranted. When these 6 participants were excluded, NOH
patients still had worse attention in the HUT position compared to controls, but this difference was
no longer significant (p = 0.066). Therefore, when participants with pre-existing cognitive
dysfunction were excluded only this one finding was altered.

3.4

Discussion

It is evident from the findings of the current study that NOH patients have undergone an alteration
in cognitive function compared to healthy age-matched controls. NOH patients had significantly
slower IPS than controls in both the supine and HUT positions. Controls had a significant increase
in IPS and attention in the HUT position compared to supine, whereas NOH patients had no
difference in IPS or attention with a change in position. NOH patients had significantly worse
attention in the HUT position compared to controls. Overall, findings demonstrate that IPS and
attention are impaired in NOH patients compared to controls.

It is important to note that NOH patients with slightly lower baseline cognitive functioning did not
cause significant differences in SDMT or Stroop test scores compared to the NOH group as a
whole. NOH patients with low MoCA scores (≤ 25) did not have significantly worse IPS or
attention than NOH patients with high MoCA scores (≥ 28) in either the supine or HUT position.
Therefore, it can be stated that NOH patients had significantly worse IPS and attention compared
to controls and this finding was not only caused by NOH patients with low MoCA scores, but it
was a result caused by the NOH group as a whole.
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During HUT, NOH patients experienced a significant drop in SBP (-64.11 ± 18.96mmHg),
demonstrating the severity of their condition. This extreme drop in SBP could be contributing to
why they had worse cognitive function than controls. The current study found no significant
correlation between the change in SBP during HUT and SDMT score or interference score in NOH
patients or controls. Therefore, when changes in SBP occurred it did not relate to changes in IPS
or attention. NOH patients experienced a significant decrease in SBP during HUT and had no
significant change in IPS or attention compared to baseline. However, control subjects experienced
very little change in SBP from the supine to HUT position but experienced a significant increase
in IPS and attention during HUT. These results contradict other studies suggesting that cognitive
function declines in patients with autonomic failure in the HUT position compared to supine 18–20.
Our findings are consistent with one study investigating patients with autonomic failure. Patients
had a SBP drop of 61.4 mmHg during HUT and had no change in sustained attention from the
supine to HUT position, whereas controls had better sustained attention in the HUT position
compared to supine 21. Consequently, the large drop in SBP experienced by NOH patients did not
cause a worsening in IPS or attention, but it could be a factor as to why NOH patients did not
experience an increase in IPS and attention during HUT like the controls.

Interestingly, NOH patients had significantly worse SDMT scores in the supine position compared
to controls but experienced no drop in SBP in this position. This indicates that regardless of
position NOH patients had slower IPS compared to controls. Prior research investigating cognitive
function in individuals who experience a large drop in BP upon standing have found that these
individuals also have alterations in many cognitive domains 4,22–27. Heims et al. documented that
out of 14 individuals with pure autonomic failure 43% showed cognitive impairment in speed,
attention, and executive functioning when tested in the seated position 4. A battery of
neuropsychological tests was completed in the seated position in 961 community dwelling
individuals. Participants with systolic orthostatic hypotension had worse global cognition, verbal
memory, and scanning and tracking scores than individuals with a normal systolic BP change 22.
Orthostatic hypotension (OH) was associated with worse cognitive function 26, as well as poorer
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global cognitive function and poorer memory, in women aged 65 and above

23

. Bocti et al.

administered multiple neuropsychological tests to 2 groups of people; group 1, individuals with
mild cognitive impairment (MCI) and OH and group 2, individuals with MCI without OH.
Individuals with MCI and OH had a lower processing speed, visual working memory, and
executive function compared to individuals without OH 24. Together these studies demonstrate that
repeated exposure to low BP may contribute to a decline in a variety of cognitive domains
regardless of position. Our results strongly argue that IPS is among the earlier domains to be
affected given that we controlled for significant other cognitive dysfunction by requiring normal
values on standardized clinical tests of cognition (i.e. MMSE and MoCA).

Attention measured by Golden’s interference score was significantly reduced in NOH patients
compared to the controls in the HUT position. As well, NOH patients had no significant difference
in attention from supine to HUT, but controls had a significant increase in attention from supine
to HUT. It is important to note that although not significant (p = 0.592) NOH patients had slightly
better attention in the supine position than controls. This was a surprising finding and may be a
result of the way Golden’s interference score is calculated since it takes into consideration a
predicted colour-word score. Prior research has reported that using this interference score can be
problematic in patient populations who have reduced IPS 28,29. When IPS is impaired it can result
in lower scores on the word trial and the colour trial of the Stroop test which results in a lower
predicted colour-word score being calculated. A low predicted colour-word score is beneficial
because it allows the participant to score low on the colour-word trial without worsening the
interference score. In the current study, the raw score for the colour-word trial was lower in NOH
patients in both the supine and HUT positions than the controls. Consequently, this demonstrates
that NOH patients perform worse on the task although their interference is not significantly worse
in the supine position.

Cerebral autoregulation maintains constant blood flow to the brain even when large fluctuations
in systemic BP occur. It has been established that SBP can range from 80 to 160mmHg and cerebral
blood flow will remain constant because of cerebral autoregulation. However, once mean BP drops
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below 80mmHg this can cause a decrease in cerebral blood flow velocity 30. This was demonstrated
in multiple system atrophy where presyncopal patients had a decrease in SBP and a corresponding
reduction in cerebral oxygenation during HUT

31

. Hunt et al. found a decrease in mean arterial

pressure by 46.7 ± 26.5mmHg, which was associated with a reduction cerebral oxygenation by 8.6
± 6.2% during HUT

32

. In the current study, 13 of the 20 NOH patients had a SBP of <80mmHg

during HUT. These BP reductions are likely disrupting the normal regulation of cerebral blood
flow in NOH patients. Consequently, monitoring cerebral hemodynamics in individuals with NOH
could show an important link between BP and orthostatic symptoms. Future research investigating
the changes in cerebral hemodynamics in NOH patients could reveal if these changes are a factor
contributing to the impaired IPS and attention. Further work is continuing in our laboratory to
address these issues.
A limitation of the current study was that all participants began cognitive testing in the supine
position. Randomizing participants to start cognitive testing in either supine or HUT position may
be beneficial. This would illustrate if cognitive test scores were affected by repeating the test in
the HUT position after the supine position. The current study showed no change in cognitive test
scores in NOH patients between the supine and HUT positions, demonstrating no learning effect
associated with the tests. The current study did not randomize starting position because our
experimental design followed the standardized HUT procedure 15. An important limitation to note
was that the NOH group had significantly lower MMSE and MoCA scores compared to controls,
demonstrating a difference in baseline cognitive function. Reduced cognitive function in the
patient group could be due to the underlying neurodegenerative disease since patients had
conditions such as Parkinson’s disease, multiple system atrophy, and Lewy body dementia.
Therefore, future research should recruit a population with only PAF patients since this condition
is not associated with cognitive changes. Another limitation was that the groups had a modest
asymmetry of recruitment based on gender. However, statistical analysis did not reveal a
significant effect of gender on our results.
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3.5

Conclusion

The current study provides evidence that IPS is significantly reduced in individuals with NOH in
both the supine and HUT positions compared to controls. Attention is also reduced in NOH patients
compared to controls in the HUT position. These findings demonstrate that NOH patients have
deficits in cognitive function compared to controls. NOH patients had no significant change in IPS
or attention from the supine to HUT positions. Therefore, patients with NOH should be informed
that they may have difficulty with how quickly they process information and that their attention
may be reduced. They should be instructed to take caution when performing daily activities in the
standing position to help reduce associated risks.

This research did not receive any specific grant from funding agencies in the public, commercial,
or not-for-profit sectors. Declarations of interest: none
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Chapter 4

4

The influence of cerebral hemodynamics on information
processing speed and attention in patients with
neurogenic orthostatic hypotension

4.1

Introduction

Cerebral blood flow requires a complex vascular system to transport oxygen and nutrients to the
most important organ, the brain. Cerebral autoregulation is a mechanism used to ensure the brain
receives adequate blood supply 1. Findings have demonstrated that the autonomic nervous system
(ANS) is involved in regulating cerebral autoregulation. Alterations to the ANS can cause a
significant decrease in cerebral blood flow velocity (CBFv), systolic pressure, and pulse pressure
2

. Biochemical evidence has suggested that the sympathetic nervous system (SNS) affects CBFv

3

. Consequently, damage or modification of the ANS disrupts cerebral autoregulation.

Neurological conditions that involve ANS damage are often associated with cerebral
hypoperfusion 4. Neurogenic orthostatic hypotension (NOH) is a condition that results from
autonomic failure and is associated with numerous neurological diseases including Parkinson’s
disease, Multiple system atrophy, and Lewy body dementia 5. NOH presents with a severe drop in
systolic blood pressure (SBP) ≥ 20mmHg or diastolic blood pressure (DBP) ≥ 10mmHg within
three minutes of standing up or head-up tilt (HUT) 6. Therefore, every time an individual with
NOH stands up, they may feel lightheaded, dizzy, weak, and confused. Repeated exposure to
orthostatic challenges with severely reduced BP can lead to cerebral hypoperfusion 7, which can
provoke deficits in cognitive function.
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Common techniques used to assess cerebral hemodynamics include transcranial doppler (TCD)
which can measure cerebral blood flow velocity (CBFv) in the middle cerebral arteries and near
infrared spectroscopy (NIRS) which measures regional cerebral oxygen saturation (rSO2) in the
frontal lobes. Measures of CBFv and rSO2 display critical information about the immediate
cerebral blood supply. Inadequate cerebral blood supply has been associated with damage to brain
tissue and deficits in cognitive function. For example, insufficient CBFv can induce brain damage
through ischemic injury 8. Cerebral hypoperfusion can cause white matter lesions, which can lead
to cognitive impairment due to disruptions in the neural networks 9. It was found that decreased
CBFv in individuals with white matter lesions was associated with greater subcortical brain
atrophy 10.

Information processing speed (IPS) and attention are two important cognitive domains that are
necessary to perform daily activities. IPS is a measure of time between receiving a stimulus and
responding to that stimulus 11. Attention is the ability to attend to a stimulus of interest without
being distracted by surrounding stimuli 12. Even in the early stages of neurological diseases such
multiple sclerosis (MS), IPS is severely impaired

13–15

. Previous research found that individuals

with NOH have decreased cognitive function, including reduced executive functions 16, immediate
visual memory, and global cognitive functioning

17

. Patients with pure autonomic failure (PAF)

presented with deficits of executive functioning, speed, and attention

18

. Individuals with Lewy

body dementia and orthostatic hypotension had worse visuospatial and attentional dysfunction
even after adjusting for cognitive impairment. These individuals also had reduced CBFv in the
occipital and temporal lobes

19

. It is evident that neurological conditions associated with NOH

have greater impairment of cognitive function. Additionally, there are a limited number of studies
examining the role of CBFv, rSO2, and BP in NOH patients. Further characterization of cerebral
hemodynamics in these patient groups are likely to provide key insights into the reason why these
individuals suffer from greater cognitive deficits. Consequently, further research is important to
determine if the reduction in IPS and attention are affected by changes in cerebral hemodynamics.

59

The objectives of the current study were two-fold. The first objective was to determine the effects
of postural blood pressure changes in NOH verses control subjects on cerebral hemodynamic
parameters (i.e. CBFv and rSO2). The second objective was to investigate cerebral hemodynamics
during tests of IPS and attention.

It was hypothesized that NOH patients would experience a reduction in CBFv and rSO2 in the
HUT position compared to the supine position, whereas controls would experience no changes in
CBFv and rSO2 with the change in position.

4.2
4.2.1

Methods
Participants

Forty-three participants were enrolled in the study. Three NOH patients were excluded because
they were unable to remain in the upright position for the duration of testing. Of the 40 participants,
20 had a diagnosis of NOH provided by a neurologist and 20 were healthy age-matched control
subjects. To diagnose NOH the neurologist evaluated the results of an autonomic reflex screen,
completed a neurological examination, and collected a medical history. A criterion of SBP ≥
30mmHg was used to determine the diagnosis of NOH rather than the more liberal criteria (i.e.
SBP ≥ 20mmHg or DBP ≥ 10mmHg). This was to reduce the false positive rate from 5% to 1 %
20

. Participants were excluded from the study if they were taking medication that could interfere

with the regulation of BP or heart rate (HR), clinically significant coronary artery disease, presence
of nerve damage in the peripheral nervous system, failure of other organ systems or diseases that
can affect autonomic function, visual problems, the inability to remain in the upright position for
the duration of testing. Testing was performed in the autonomic lab located at the University
Hospital in London, Ontario. Written informed consent was provided before participants were
enrolled in the study. The Health Science Research Ethics Board at Western University granted
ethical approval for the current study.
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4.2.2

Physiological Measures

A standardized autonomic reflex screen (ARS) was used to assess the integrity of the ANS 21. The
ARS evaluates the quality of the postganglionic sympathetic sudomotor axons using the
quantitative sudomotor axon reflex test, cardiovagal function using a deep breathing test and the
Valsalva maneuver, and adrenergic function using the Valsalva maneuver and head-up tilt (HUT).

During testing participants were connected to a HR monitor (Model 3000 Cardiac Trigger Monitor,
IVY Biomedical Systems, Inc., Branford, CT) attached using electrocardiography electrodes
(Ambu® Blue Sensor SP, Glen Burnie, MD). Electrode placement was as follows; one just below
the right clavicle, one just below the left clavicle, and one on the lower chest just above and left of
the umbilicus. Participants were also connected to a beat-to-beat BP monitor (BMEYE Nexfin
device, Amsterdam, Netherlands) fastened on the middle finger. TCD probes at 2MHz were
positioned over the left and right middle cerebral arteries to continuously measure CBFv (Multigon
500M, DWL MultiDop-T, Neuroscan). The probes were fastened in place with an adjustable
plastic headpiece. The strongest CBFv signal on either the left or right side was used for analysis.
NIRS was used to measure rSO2 in the left and right frontal lobes (NIRS ForeSight® cerebral
oximeter, CASMED, Branford, CT). WR TestWorks TM software (WR Medical Electronics Co.,
Stillwater, MN) was used to record data.

4.2.3

Cognitive Measures

The Mini-Mental State Examination and the Montreal Cognitive Assessment were used to
clinically screen participants to ensure they did not have any cognitive impairment. Two paper
based neuropsychological tests were used to assess cognitive function; the oral version of the
Symbol Digit Modalities Test (SDMT) to measure IPS and the Stroop test to measure attention.
The SDMT is a sheet of paper with a key at the top of the page containing the numbers 1 to 9 and
each number corresponds with a symbol below. Underneath the key there are 8 rows containing
15 symbols each. Participants were given 90 seconds to say out loud as quickly as possible the
digit associated with each symbol 22. The Stroop test consists of three subtests each containing 100
words of colours (purple, blue, red, green, and brown) and lasting 45 seconds in duration. The first
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test is composed of words of colours written in black ink. The second test is composed of words
of colours printed in the same colour ink as the word. In the third test the words of colours are
printed in a colour of ink that does not correspond with the word. For example, the word blue could
be printed in green ink. During this trial the participant must say the colour of the ink and inhibit
themselves from saying the word. The number of correct responses and the number of errors were
recorded for all tests.

Before cognitive testing commenced 90 seconds was recorded in the supine position to provide
baseline resting values for HR, MAP, CBFv, and rSO2. In the supine position cognitive testing
was completed in the following order; SDMT, Stroop 1, SDMT, Stroop 2, SDMT, Stroop 3,
SDMT. The bed was then tilted to the HUT position (70 degrees upright) and 90 seconds was
recorded in this position before cognitive testing began. Cognitive testing in the HUT position was
as follows; Stroop 1, Stroop 2, Stroop 3, SDMT. Total time in the upright position was about seven
minutes. Upon completion of cognitive testing the bed was tilted back to the supine position and
the participant was given five minutes of recovery.

4.2.4

Statistical Analysis

Characteristics such as age, BMI, HR and BP were compared between groups using independentsamples t-tests. Cognitive testing in the supine and HUT positions was compared using a two-way
mixed ANOVA. CBFv, rSO2, and MAP were measured during baseline, cognitive testing, and
HUT and were analyzed using a two-way mixed ANOVA. These measures were also compared
between NOH and controls using independent-samples t-tests. Repeated measures with a
Bonferroni correction was used to compare each position to baseline. All data are expressed as
mean ± SD. A significance level of p < 0.05 was used. SPSS statistics software, Version 25,
Manufactured by International Business Management (IBM) Corporation was used for the
statistical analysis.

62

Results

4.3
4.3.1

Participants

Various characteristics of NOH patients and controls are presented in Table 3. Participants with
NOH had the following associated conditions; Parkinson’s disease (n=11), multiple system
atrophy (n=3) and early Lewy body dementia based on preganglionic dysfunction (n=1) and 5
participants had a diagnosis of idiopathic NOH. Controls and NOH patients were matched based
on age, BMI, and education level. There were no significant differences found based on gender
even though there was a slight difference in the female to male ratios. There was no significant
difference in resting HR, resting BP, or the change in HR between groups. The change in SBP
during HUT was significantly greater in NOH patients (64.11 ± 18.96) than controls (-5.69 ± 7.65).

Table 3. Participant Characteristics
Characteristic

Control
(mean ± SD)

NOH
(mean ± SD)

P-value

Age (years)

64.50 ± 9.25

69.55 ± 7.43

p = 0.065

12:8

8:12

16

13

BMI (kg/m2)

21.50 ± 2.51

22.02 ± 4.71

p = 0.67

Resting HR (bpm)

69.49 ± 11.91

74.28 ± 12.85

p = 0.228

ΔHR during HUT (bpm)

15.04 ± 6.27

12.12 ± 8.60

p = 0.227

128.12 ± 18.75

139.50 ± 23.72

p = 0.101

-5.69 ± 7.65

-64.11 ± 18.96 *

p < 0.001*

Gender (F:M)
Education Level (>high school)

Resting SBP (mmHg)
ΔSBP during HUT (mmHg)

BMI: body mass index, bpm: beats per minute, HR: heart rate, HUT: head-up tilt, mmHg:
millimeters of mercury, NOH: neurogenic orthostatic hypotension, SBP: systolic blood pressure.
* Represents significant difference of p < 0.001.
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4.3.2

SDMT and Stroop Test Scores

NOH patients scored significantly worse on the SDMT in both the supine and HUT positions
compared to the controls (p < 0.001), demonstrating significantly slower IPS. NOH patients had
no significant difference in IPS from supine to HUT, whereas controls had a significant increase
in IPS in the HUT position compared to supine. NOH patients also scored significantly worse on
the Stroop test in the HUT position compared to controls, indicating worse attention. Controls had
significantly better attention in the HUT position compared to the supine position, whereas the
NOH patients had no significant difference (Table 4).

Table 4. Cognitive test scores in Supine and HUT Positions
Cognitive Test

Position

Control
(mean ± SD)

NOH
(mean ± SD)

P-value

SDMT

Supine

63.55 ± 9.96

43.20 ± 15.26

p < 0.001*

HUT

69.90 ± 12.02

42.90 ± 14.33

p < 0.001*

Supine

-14.01 ± 8.96

-12.38 ± 9.32

p = 0.592

HUT

-8.68 ± 7.13

-14.86 ± 8.96

p = 0.029*

Stroop Test

HUT: head-up tilt, NOH: neurogenic orthostatic hypotension, SDMT: symbol digit modalities test.
* Represents significant difference between groups
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4.3.3

Cerebral Blood Flow Velocity

Baseline values for CBFv were not significantly different between groups. Controls had a resting
CBFv of 50.78 ± 10.79cm/sec and NOH patients of 47.83 ± 10.77cm/sec. During the Stroop test
(Figure 10) and the SDMT (Figure 11) in the supine position there was no significant change in
CBFv from baseline in either group. NOH patients had a significant decrease in CBFv by 6.04cm/sec during HUT compared to baseline, whereas the control group had no significant
change. During HUT, CBFv decreased significantly during the Stroop test by -6.24cm/sec and
during the SDMT by -7.42cm/sec compared to baseline in NOH patients, whereas controls had no
significant change in CBFv. CBFv was significantly different between NOH and controls during
HUT, during Stroop testing in the supine and HUT positions and during the SDMT in the HUT
position.
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Figure 10. Cerebral Blood Flow Velocity during Baseline, Stroop Testing, and Head-up Tilt

There was a significant decrease in CBFv from baseline compared to HUT and from baseline
compared to Stroop test in the HUT position in the NOH group. Controls had no significant
changes in CBFv. There were differences in CBFv between groups during Stroop testing in the
supine and HUT positions. CON: control, HUT: head-up tilt, NOH: neurogenic orthostatic
hypotension. a: p = 0.007 between baseline and HUT; b: p = 0.003 between baseline and HUT
Stroop test; c: p = 0.017 between NOH and CON during supine Stroop test; d: p = 0.006 between
NOH and CON during HUT Stroop test.
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Figure 11. Cerebral Blood Flow Velocity during Baseline, SDMT Testing, and Head-up Tilt

There was a significant decrease in CBFv from baseline compared to HUT and from baseline
compared to SDMT in the HUT position in the NOH group. Controls had no significant changes
in CBFv. There were differences in CBFv between groups during HUT and HUT SDMT. CON:
control, HUT: head-up tilt, NOH: neurogenic orthostatic hypotension, SDMT: symbol digit
modalities test. a: p = 0.003 between baseline and HUT; b: p = 0.002 between baseline and HUT
SDMT; c: p = 0.036 between NOH and CON during HUT; d: p = 0.014 between NOH and CON
during HUT SDMT.
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4.3.4

Regional Cerebral Oxygen Saturation

At baseline there was no significant difference in rSO2 between groups. Baseline rSO2 was 69.74
± 3.55% for controls and 70.31 ± 4.58% for NOH patients. When cognitive testing commenced
in the supine position rSO2 increased significantly in both groups by 3.78% and 1.55% during
the Stroop test (Figure 12) and 4.25% and 1.85% during SDMT (Figure 13) in control and NOH
groups respectively. During HUT, rSO2 decreased significantly from baseline by -1.85% in the
NOH group and no significant change in the control group. During cognitive testing in the HUT
position, NOH patients had a significant decrease in rSO2 during the Stroop test by -5.87% and
during the SDMT by -5.48% compared to baseline. The controls had no significant change in
rSO2 during cognitive testing in the HUT position compared to baseline. There were significant
differences in rSO2 between NOH and controls during the HUT Stroop test and HUT SDMT.
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Figure 12. Cerebral Oxygen Saturation during Baseline, Stroop Testing, and Head-up Tilt

Controls and NOH had a significant increase in rSO2 between baseline and Stroop testing in the
supine position. NOH patients experienced a significant decrease in rSO2 between baseline and
HUT and between baseline and Stroop testing in the HUT position. There was a difference in rSO2
between groups during HUT Stroop test. NOH: neurogenic orthostatic hypotension, CON: control,
HUT: head-up tilt. a: p = 0.00009 between baseline and Stroop testing in the supine position; b: p
= 0.019 between baseline and Stroop testing in the supine position; c: p = 0.041 between baseline
and HUT positions; d: p = 0.0001 between baseline and Stroop testing in the HUT position; e: p =
0.029 between NOH and CON during the HUT Stroop test.
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Figure 13. Cerebral Oxygen Saturation during Baseline, SDMT Testing, and Head-up Tilt
Controls and NOH had a significant increase in rSO2 between baseline and SDMT testing in the
supine position. NOH patients experienced a significant decrease in rSO2 between baseline and
HUT and between baseline and HUT SDMT. There was a difference in rSO2 between groups
during HUT SDMT. CON: control, HUT: head-up tilt, NOH: neurogenic orthostatic hypotension,
SDMT: symbol digit modalities test. a: p = 0.003 between baseline and supine SDMT testing in
CON; b: p = 0.043 between baseline and supine SDMT testing in NOH; c: p = 0.025 between
baseline and HUT in NOH; d: p = 0.004 between baseline and HUT SDMT testing in NOH; e: p
= 0.013 between NOH and CON during the HUT SDMT.
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4.3.5

Mean Arterial Pressure

Mean arterial pressure (MAP) at baseline was not significantly different between groups. Resting
MAP for controls was 94.02 ± 15.01mmHg and 92.87 ± 19.66mmHg for NOH patients. There was
no significant change in MAP during cognitive testing in the supine position compared to baseline
in either group. During HUT there was a significant decrease in MAP from baseline in the NOH
group, MAP dropped by -24.62mmHg, whereas there was no significant change in controls. MAP
remained significantly reduced from baseline during the Stroop test in the HUT position (Figure
14) and the SDMT in the HUT position (Figure 15), MAP decreased by -19.25mmHg and 24.02mmHg, respectively. There was no significant change in MAP in the control group during
cognitive testing in the HUT position. MAP was significantly different between groups during
HUT and during HUT Stroop and HUT SDMT.
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Figure 14. Mean Arterial Pressure during Baseline, Stroop Testing and Head-up Tilt

NOH patients experienced a significant decrease in MAP between baseline and HUT and between
baseline and HUT Stroop testing. Controls had no significant changes in MAP. There were
differences in MAP between groups during HUT and HUT Stroop test. CON: control, HUT: headup tilt, NOH: neurogenic orthostatic hypotension. a: p = 0.004 between baseline and HUT; b: p =
0.035 between baseline and HUT Stroop testing; c: p = 0.006 between NOH and CON during
HUT; d: p = 0.0002 between NOH and CON during the HUT Stroop test.
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Figure 15. Mean Arterial Pressure during Baseline, SDMT Testing and Head-up Tilt
NOH patients experienced a significant decrease in MAP between baseline and HUT and between
baseline and HUT SDMT testing. Controls had no significant changes in MAP. There were
differences in MAP between groups during HUT and HUT SDMT. CON: control, HUT: head-up
tilt, NOH: neurogenic orthostatic hypotension, SDMT: symbol digit modalities test. a: p = 0.0004
between baseline and HUT; b: p = 0.01 between baseline and HUT SDMT testing; c: p = 0.001
between NOH and CON during HUT; d: p = 0.0001 between NOH and CON during HUT SDMT.
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4.4

Discussion

Findings demonstrated that NOH patients had significantly impaired CBFv, rSO2, and MAP during
HUT. NOH patients had a significant decrease in these three measurements during HUT compared
to baseline, whereas controls had no significant difference. Baseline values for mean CBFv, rSO2,
and MAP were not significantly different between groups. This revealed that the two groups had
similar resting hemodynamic values. These measures differed significantly between groups during
the orthostatic challenge and during cognitive testing. Previous research analyzing changes in
CBFv, rSO2, and MAP presented similar findings

23–27

. A five minute orthostatic challenge

produced a larger decrease in MAP and rSO2 in patients with sympathetic failure than controls 25.
A study assessed changes in cerebral hemodynamics during HUT in 18 patients with autonomic
failure and 10 controls. Results showed that 10 minutes of HUT caused a greater reduction in MAP
(-46.7 ± 26.5mmHg) and cerebral oxygenation (-8.6 ± 6.2%) in patients than controls

28

. It was

found that 13 individuals with orthostatic hypotension had decreased MAP (-19.1 ± 11.6mmHg)
and cerebral oxygenation (-5.4 ± 4.2%) during HUT 23. During HUT, individuals with multiple
system atrophy who experienced presyncopal symptoms had a significant decline in SBP and a
corresponding reduction in rSO2

26

. Therefore, it has been established that individuals who

experience a significant drop in BP upon standing likely have profound changes in cerebral
hemodynamics.

An interesting finding was that rSO2 increased significantly from baseline in both the NOH patients
and controls when cognitive testing commenced in the supine position. This increase in rSO2 with
no positional change reveals that cognitive testing likely triggered the rise in rSO2. Attention and
IPS was required to complete the cognitive tasks, consequently the region of the brain responsible
for these cognitive functions had an increased metabolic demand. Evidence has supported the
finding that cognitive testing causes an increase in rSO2. It has been stated that increased in rSO2
demonstrates increased neural activity, which is necessary during cognitive testing. A group of
highly fit women had better cognitive performance than a group of low fit women likely due to
the fact that the highly fit women also experienced a greater increase in rSO2

29

. In the current

study, NOH patients had lower rSO2 during cognitive testing and had worse cognitive test scores
than controls. Consequently, reduced rSO2 could be contributing to impaired cognitive function.
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A study assessing patients undergoing chronic hemodialysis demonstrated that rSO2 was
significantly lower in cognitively impaired patients compared to cognitively normal patients (48 ±
9 vs. 57 ± 10%, p = 0.01)

30
.

It is apparent that reduced rSO2 is related to changes in cognitive

function.

The second objective of the study was to assess cerebral hemodynamics and investigate if it
changes during cognitive testing in the supine and HUT positions. The current study provides
insight that NOH patients had an alteration in cerebral hemodynamics which can help provide a
reason as to why these individuals also have decreased IPS and attention compared to controls.
NOH patients had a significant decrease in CBFv and rSO2 compared to baseline during cognitive
testing in the HUT position suggesting that during this time oxygen availability was insufficient
to meet the metabolic demands of the cognitive processes 31. Compared to controls, NOH patients
had significantly reduced CBFv and rSO2 during cognitive testing in the HUT position and reduced
CBFv during the Stroop test in the supine position. Cerebral hypoperfusion occurs in the upright
position in NOH patients and is likely playing a role in why they have impaired cognitive
functioning. Surprisingly, NOH patients had no significant difference in IPS or attention when
they changed position from supine to HUT but compared to controls had significantly worse IPS
and attention. Therefore, NOH patients had impaired IPS and attention regardless of their position.
These findings are in line with a study that assessed 10 patients with symptomatic NOH and 10
healthy controls. They found that NOH patients had no significant difference in sustained attention
from the supine to HUT position but the controls did have a significantly better attention in HUT
position 32. It is important to note that controls had an increase in CBFv and a significant increase
in rSO2 during cognitive testing in the supine position compared to baseline values. As well,
controls also had an increase in CBFv during cognitive testing in the HUT position compared to
HUT values. These findings indicate that cerebral hemodynamic values may increase during
cognitive tasks since they trigger an increase in cognitive activation.

In the current study, controls had a significant increase in attention and IPS in the HUT position
compared to supine. The activity of standing results in an increase in sympathetic activation which
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may contribute to a brief improvement in cognitive function. When cognitive tasks are performed
they elicit greater sympathetic nervous system activation

33

. It has been stated that greater

sympathetic activity is associated with improved attention processing and greater parasympathetic
activity is an indicator of increased selective attention

34

. Given that NOH patients have no

improvement or possibly worse cognitive function in the standing position reveals that the ANS
damage in this group of individuals that results in impaired sympathetic activation could result in
this cognitive dysfunction. This provides evidence that deficits in cognitive function experience
by NOH patients are partly due to direct ANS damage

Our study proposes that NOH patients have impaired cognitive function independent of position.
NOH patients experience repeated exposure to cerebral hypoperfusion. This could be related to
why they have a persistent deficit in cognitive functioning. When SBP drops below 80mmHg,
cerebral autoregulation may not be able to function properly resulting in decreased cerebral blood
flow. Individuals with neutrally mediated syncope are close to losing consciousness when SBP
drops to 60mmHg, at this time they also experience a large reduction in mean CBFv to 30cm/s 35.
It has been stated that cerebral hypoperfusion has negative consequences on brain structures

8,9

.

Therefore, daily exposure to reduced CBFv, rSO2, and MAP elicited by an orthostatic challenge
could damage the integrity of neural connections involved in cognitive processes. For example,
cerebral white matter damage has been strongly associated with decreased executive functions and
IPS 36. Alterations in BP and cerebral hemodynamics are likely a contributing factor to the decline
in cognitive function.

The current study consisted of a diverse patient population, but as a group these patients had a
homogeneous drop in BP as a result of autonomic function. Patients had a diagnosis of NOH but
had different associated conditions, such as Parkinson’s disease, multiple system atrophy, and
Lewy body dementia. Future studies could repeat this protocol with a specific group of patients,
for example Parkinson’s disease patients with NOH. This could provide evidence if the changes
in cerebral hemodynamics and cognitive function are related to NOH or the associated condition.
Another limitation of the study was that some participants only had unilateral TCD recordings if a
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signal could not be obtained bilaterally. Bilateral recordings are important since CBFv responses
during cognitive tasks strongly differ between hemispheres

37,38

. Fortunately, most of the

participants in the current study had bilateral recording but not all, consequently we measured the
strongest recording obtained. Therefore, future studies should attempt to attain bilateral TCD
recordings on all participants when assessing cognitive function.

4.5

Conclusion

The current study has provided evidence that NOH patients experience decreased CBFv and rSO2
during an orthostatic challenge which could be a contributing factor to impaired IPS and attention.
NOH patients experienced reduced IPS and attention in both the supine and HUT positions
compared to controls and have no significant difference in these cognitive processes with a change
in position. Therefore, this decline in cognitive function in NOH patients is likely in part a result
of daily exposure to hypoperfusion and damage of the ANS.
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Chapter 5

5

General Discussion

This thesis aimed to determine if there was a relationship between NOH patients, cerebral
hemodynamics, IPS and attention. Analysis of the data revealed that NOH patients had significant
differences in cerebral hemodynamics and cognitive functioning compared to healthy controls.
The findings of the current thesis support some and reject some of the hypotheses made.

5.1

Supported and Rejected Hypotheses

The first hypothesis that NOH patients would experience a decline in IPS and attention in the HUT
position due to the associated reduction in postural BP compared to the supine position was
rejected. Even though during HUT NOH patients had a large drop in SBP they experienced no
significant difference in IPS or attention between the supine and HUT positions. The hypothesis
that control subjects would have increased IPS and attention in the HUT position compared to the
supine position was accepted. It was found that controls had significantly faster IPS and better
attention in the HUT position compared to supine. This could be due to the fact that they experience
a burst of sympathetic activity when they stand up, which could increase cognitive function. NOH
patients have ANS damage therefore they lack the burst of sympathetic activity when they stand
up and consequently do not experience an increase in IPS and attention. Overall, NOH patients
had worse IPS in the supine and HUT positions compared to controls. As well, NOH patients had
worse attention in the HUT position compared to controls.

The second hypothesis predicted that the magnitude of the postural SBP drop would correspond
with a worsening in IPS and attention. This hypothesis was rejected since no correlation was found
between the postural SBP drop and IPS or attention in either NOH patients or controls. Therefore,
the drop in SBP was not related to worse performance on the cognitive tasks.

82

The third hypothesis that NOH patients would experience a reduction in CBFv and rSO2 in the
HUT position compared to the supine position was accepted. NOH patients experienced a
significant reduction in both CBFv and rSO2 during the HUT position, therefore these measures
were also reduced during cognitive testing in the HUT position. As well, the hypothesis that
controls would experience no change in CBFv and rSO2 from the supine to HUT position was also
accepted. This finding indicates that controls have adequate cerebral blood supply during cognitive
testing in the HUT position.

It is likely that the fourth hypothesis was accepted. It was predicted that reduced measures of CBFv
and rSO2 could be related to a decline in IPS and attention. Evidence to support this hypothesis is
that NOH patients have significantly reduced IPS and attention compared to controls and they also
experience reductions in cerebral blood supply when they are in the upright position. It is believed
that repeated exposure to reduced CBFv and rSO2 could lead to a decline in cognitive functioning.

The most important finding was that overall NOH patients had reduced IPS compared to controls
regardless of their position. Therefore, IPS is permanently reduced in NOH patients compared to
controls. Reduced IPS and attention could be related to the fact that NOH patients experience
repeated episodes of cerebral hypoperfusion every time they perform an activity in the upright
position. Consequently, exposure to cerebral hypoperfusion could be negatively affecting
cognitive function.

5.2

Strengths and Limitations

There were several strengths with regards to the current study. This study investigated a clinical
population that is rarely studied and provided information about their cognitive function and
cerebral hemodynamics. The current study assessed cognitive function in both the supine and HUT
positions. It was beneficial to measure cognition in these two positions since NOH patients
experience positional BP changes. There is limited literature about cerebral hemodynamics in
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NOH patients, therefore this study introduced information about these measurements during
cognitive testing and during changes in position. Another strength of the current study was that a
group of healthy age-matched control subjects was included to provide baseline cognitive function
and cerebral hemodynamics, which was then compared to the NOH patients.

Despite the strengths highlighted there were a few limitations of the current study. Randomizing
participants to start cognitive testing in either the supine or the HUT position would have been
beneficial. This would prove if cognitive test scores were affected by repeating the test in the HUT
position after the supine position. The current study showed no change in cognitive test scores in
NOH patients between the supine and HUT positions, demonstrating no learning effect associated
with the tests. The study had a modest asymmetry in the male to female ratios in both the NOH
and control groups. However, statistical analysis did not reveal a significant effect of gender on
the results. The study consisted of a diverse patient population, but as a group these patients had a
homogeneous drop in BP as a result of autonomic function. Patients had a diagnosis of NOH but
had different associated conditions, such as PD, MSA, and LBD. Future studies should repeat this
protocol with a specific group of patients, for example PD patients with NOH. This would provide
evidence if the changes in cerebral hemodynamics and cognitive function are related to NOH or
the associated condition.

5.3

Future Directions

Future research should aim to investigate if repeated exposure to cerebral hypoperfusion in NOH
patients is related to changes in brain structure and function. This could provide evidence as to
why NOH patients have permanently reduced IPS and attention compared to controls. Future
research should also investigate other cognitive domains to determine if NOH patients have
impairments in functions other than IPS and attention.
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5.4

Conclusion

This is the first study to investigate the relationship between NOH patients, cerebral
hemodynamics and cognitive function in both the supine and HUT positions. Findings revealed
that NOH patients had a significant decrease in CBFv and rSO2 during HUT compared to supine,
as well NOH patients experienced reduced IPS and attention compared to control subjects.
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